ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

SEC Filings

Investors & Media

  • Home
  • Investors & Media
  • SEC Filings
Investors & Media

Investors & Media

  • Overview
  • News / Events
  • Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Filter Filings:
Date Form Description Docs XBRL Pages
06/17/20 4 Statement of changes in beneficial ownership of securities 2
06/17/20 8-K Current report filing 3
06/17/20 3 Initial statement of beneficial ownership of securities
Related Documents
EX-24.3_922921
2
06/15/20 4 Statement of changes in beneficial ownership of securities 1
06/01/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
05/29/20 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 10
05/27/20 8-K Current report filing
Related Documents
EX-1.1
EX-4.1
EX-4.2
EX-4.3
EX-5.1
EX-10.1
149
05/26/20 424B5 Prospectus filed pursuant to Rule 424(b)(5) 65
05/21/20 S-3MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-3
Related Documents
EX-23.2
6
05/21/20 424B5 Prospectus filed pursuant to Rule 424(b)(5) 65
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...44
  • Next >>
© 2021 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter